000250.KQ

N/A

Sam Chun Dang Pharm. Co., Ltd — PEG Ratio Analysis

—

PEG Ratio

Negative EPS growth — PEG not meaningful when earnings are declining

—

Current Price

$339000.00

TTM EPS

$439.20

P/E Ratio

771.86

Growth Rate

-5.1%

3-Year EPS CAGR

Sector

Healthcare

Medical - Pharmaceuticals

Calculated

6/17/2026

9:42:52 AM

PEG Ratio Unavailable

Negative Growth — PEG not meaningful

Peer Comparison

Sample Size

3 peers

Industry Median PEG

0.15

25th Percentile

0.00

75th Percentile

80.02

Symbol	Company	PEG	P/E	Growth	vs 000250.KQ
039200.KQ	Oscotec Inc.	0.00	28.8	5870.2%	—
069620.KS	Daewoong pharmaceutical Co.,Ltd	0.15	7.5	49.7%	—
000100.KS	Yuhan Corporation	80.02	33.6	0.4%	—

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.